• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Phlexglobal acquires Net Solutions Europe, a specialist software development company

Phlexglobal acquires Net Solutions Europe, a specialist software development company

January 13, 2016
CenterWatch Staff

Phlexglobal, a global provider of Trial Master File (TMF) technology and services for the global life sciences industry, has acquired Net Solutions Europe (NSE), a U.K.-based technology company delivering software solutions.

Phlexglobal has been working in partnership with NSE since 2010 on the development of PhlexEview; its market leading electronic TMF (eTMF) cloud based platform. The acquisition fortifies its position at the forefront of the provision of eTMF solutions and technology enabled services.

Peter McNaney, Phlexglobal chief technology officer, said, “As Phlexglobal’s technology partner, NSE has demonstrated a regulatory understanding of the sensitivity of the clinical documents we handle, and their expertise and experience is second to none. We also have appointed an expert eTMF product manager working as part of the newly expanded technology team, and this appointment coupled with the NSE acquisition will further ensure we are at the leading edge of eTMF technology capabilities.”

Rick Riegel, chief executive officer said, “This acquisition allows us to fast-track the future development of PhlexEview, our cloud based eTMF platform. The resulting enhanced capabilities will provide significant additional benefits to both our software and our services clients.”

Phlexglobal is committed to developing technology solutions for the TMF market to expedite study start up, facilitate regulatory inspection readiness, and improve management and oversight. The technology of choice for over 30 global companies, ranging from top 10 Pharma to biotech and CROs with thousands of worldwide users, a major new release of PhlexEview is anticipated later this year.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing